TABLE OF CONTENTS
Volume 28, Issue 2 (15 January 2009)
Original Articles
Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors
J R Smith, P A Clarke, E de Billy and P Workman
Oncogene 28: 157-169; advance online publication, October 20, 2008; doi:10.1038/onc.2008.380
Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe
Y W Chan, Y Chen and R Y C Poon
Oncogene 28: 170-183; advance online publication, September 29, 2008; doi:10.1038/onc.2008.369
Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells
S H Lee, J Kim, W-H Kim and Y M Lee
Oncogene 28: 184-194; advance online publication, October 13, 2008; doi:10.1038/onc.2008.377
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
M Mourtada-Maarabouni, M R Pickard, V L Hedge, F Farzaneh and G T Williams
Oncogene 28: 195-208; advance online publication, October 6, 2008; doi:10.1038/onc.2008.373
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, P A Convery, N Matsumura, R S Whitaker, E Kondoh, T Perry, Z Huang, R C Bentley, S Mori, S Fujii, J R Marks, A Berchuck and S K Murphy
Oncogene 28: 209-218; advance online publication, October 6, 2008; doi:10.1038/onc.2008.374
Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis
A Raafat, S Lawson, S Bargo, M Klauzinska, L Strizzi, A S Goldhar, K Buono, D Salomon, B K Vonderhaar and R Callahan
Oncogene 28: 219-230; advance online publication, October 6, 2008; doi:10.1038/onc.2008.379
Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K Hatano, J Kikuchi, M Takatoku, R Shimizu, T Wada, M Ueda, M Nobuyoshi, I Oh, K Sato, T Suzuki, K Ozaki, M Mori, T Nagai, K Muroi, Y Kano, Y Furukawa and K Ozawa
Oncogene 28: 231-242; advance online publication, October 13, 2008; doi:10.1038/onc.2008.385
HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
D Mottet, S Pirotte, V Lamour, M Hagedorn, S Javerzat, A Bikfalvi, A Bellahcène, E Verdin and V Castronovo
Oncogene 28: 243-256; advance online publication, October 13, 2008; doi:10.1038/onc.2008.371
MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer
A Vecchione, M Fassan, V Anesti, A Morrione, S Goldoni, G Baldassarre, D Byrne, D D'Arca, J P Palazzo, J Lloyd, L Scorrano, L G Gomella, R V Iozzo and R Baffa
Oncogene 28: 257-269; advance online publication, October 20, 2008; doi:10.1038/onc.2008.381
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-
B target genes by interaction with NFKBIZ
M Göransson, M K Andersson, C Forni, A Ståhlberg, C Andersson, A Olofsson, R Mantovani and P Åman
Oncogene 28: 270-278; advance online publication, October 13, 2008; doi:10.1038/onc.2008.378
The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells
K J Feres, I Ischenko and M J Hayman
Oncogene 28: 279-288; advance online publication, October 6, 2008; doi:10.1038/onc.2008.383
Inhibition of Siah ubiquitin ligase function
A Möller, C M House, C S F Wong, D B Scanlon, M C P Liu, Z Ronai and D D L Bowtell
Oncogene 28: 289-296; advance online publication, October 13, 2008; doi:10.1038/onc.2008.382
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling
T Kojima, T Shimazui, S Hinotsu, A Joraku, T Oikawa, K Kawai, R Horie, H Suzuki, R Nagashima, K Yoshikawa, T Michiue, M Asashima, H Akaza and K Uchida
Oncogene 28: 297-305; advance online publication, October 20, 2008; doi:10.1038/onc.2008.391
Short Communication
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C A Crane, A Panner, J C Murray, S P Wilson, H Xu, L Chen, J P Simko, F M Waldman, R O Pieper and A T Parsa
Oncogene 28: 306-312; advance online publication, October 13, 2008; doi:10.1038/onc.2008.384
